Team
The people behind FIM.
Founders, management, board and advisors — the experience behind ATI's ophthalmology and medical device innovation.
Founders, management, board and advisors — the experience behind ATI's ophthalmology and medical device innovation.
Many years of senior management experience, including roles at Microsoft. Founder of Medit Interactive Medical Technologies and inventor of the patent underlying FIM's technology.
Vast experience in multi-disciplinary R&D project management and hardware development, with senior roles at Teledata Networks, Seabridge Networks, FlexLight Networks and Nokia Siemens Networks Israel. B.Sc. in Electrical Engineering, Tel Aviv University.
Senior ophthalmologist at Meir Medical Center and head of the Uveitis Services, leading research in glaucoma treatment. M.D. cum laude, University of Bologna. Passed away in April 2014.
Leads ATI's strategy and day-to-day operations, drawing on senior management experience including roles at Microsoft.
Leads R&D, drawing on senior hardware and telecom engineering experience across Teledata, Seabridge and Nokia Siemens Networks.
Director, Cornea Unit & Anterior Segment, Tel Aviv Sourasky Medical Center. Studied medicine and earned a Master in Eye Medicine at Tel Aviv University; specialized in Cornea and Anterior Segment Medicine in Philadelphia, USA.
Two decades in early-stage technology enterprises as investor, advisor and founder. Founding president of ISEMI. Director at Clal Industries, Discount Issuers, Bezeq Globe, RIT, RadWare and RadVision. PhD in International Economics, Graduate Institute of International Studies, Geneva.
33 years of experience as a partner at Ernst & Young Israel, specializing in Life-Science and high-tech. Advised on IPOs, M&A, and fund raising across Israel, the U.S. and Europe.
Self-made Israeli entrepreneur with over 30 years leading international business operations, including founding Toyo Ram Electronics and Supertec Electronics, and Soligor Technologies Ltd.
Clinical and scientific advisor to ATI.
Clinical and scientific advisor to ATI.
Scientific advisor to ATI.
C.H. Health is a private investment firm with holdings in several companies. Mr. Chaim Hurvitz has served as CEO of C.H. Health since May 2011.